United States Pertussis Vaccine Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Pertussis Vaccine Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Pertussis Vaccine Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Pertussis Vaccine Overall Market Size
2.1 United States Pertussis Vaccine Market Size: 2021 VS 2027
2.2 United States Pertussis Vaccine Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Pertussis Vaccine Sales: 2016-2027
3 Company Landscape
3.1 Top Pertussis Vaccine Players in United States Market
3.2 Top United States Pertussis Vaccine Companies Ranked by Revenue
3.3 United States Pertussis Vaccine Revenue by Companies
3.4 United States Pertussis Vaccine Sales by Companies
3.5 United States Pertussis Vaccine Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Pertussis Vaccine Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Pertussis Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Pertussis Vaccine Players in United States Market
3.8.1 List of Tier 1 Pertussis Vaccine Companies in United States
3.8.2 List of Tier 2 and Tier 3 Pertussis Vaccine Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Pertussis Vaccine Market Size Markets, 2021 & 2027
4.1.2 Whole-cell Vaccines
4.1.3 Acellular Vaccines
4.2 By Type - United States Pertussis Vaccine Revenue & Forecasts
4.2.1 By Type - United States Pertussis Vaccine Revenue, 2016-2021
4.2.2 By Type - United States Pertussis Vaccine Revenue, 2022-2027
4.2.3 By Type - United States Pertussis Vaccine Revenue Market Share, 2016-2027
4.3 By Type - United States Pertussis Vaccine Sales & Forecasts
4.3.1 By Type - United States Pertussis Vaccine Sales, 2016-2021
4.3.2 By Type - United States Pertussis Vaccine Sales, 2022-2027
4.3.3 By Type - United States Pertussis Vaccine Sales Market Share, 2016-2027
4.4 By Type - United States Pertussis Vaccine Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Pertussis Vaccine Market Size, 2021 & 2027
5.1.2 Children
5.1.3 Adults
5.2 By Application - United States Pertussis Vaccine Revenue & Forecasts
5.2.1 By Application - United States Pertussis Vaccine Revenue, 2016-2021
5.2.2 By Application - United States Pertussis Vaccine Revenue, 2022-2027
5.2.3 By Application - United States Pertussis Vaccine Revenue Market Share, 2016-2027
5.3 By Application - United States Pertussis Vaccine Sales & Forecasts
5.3.1 By Application - United States Pertussis Vaccine Sales, 2016-2021
5.3.2 By Application - United States Pertussis Vaccine Sales, 2022-2027
5.3.3 By Application - United States Pertussis Vaccine Sales Market Share, 2016-2027
5.4 By Application - United States Pertussis Vaccine Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Sanofi Pasteur
6.1.1 Sanofi Pasteur Corporation Information
6.1.2 Sanofi Pasteur Overview
6.1.3 Sanofi Pasteur Pertussis Vaccine Sales and Revenue in United States Market (2016-2021)
6.1.4 Sanofi Pasteur Pertussis Vaccine Product Description
6.1.5 Sanofi Pasteur Recent Developments
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Overview
6.2.3 GSK Pertussis Vaccine Sales and Revenue in United States Market (2016-2021)
6.2.4 GSK Pertussis Vaccine Product Description
6.2.5 GSK Recent Developments
6.3 Mitsubishi Tanabe Pharma
6.3.1 Mitsubishi Tanabe Pharma Corporation Information
6.3.2 Mitsubishi Tanabe Pharma Overview
6.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales and Revenue in United States Market (2016-2021)
6.3.4 Mitsubishi Tanabe Pharma Pertussis Vaccine Product Description
6.3.5 Mitsubishi Tanabe Pharma Recent Developments
6.4 Wuhan Institute of Biological Products
6.4.1 Wuhan Institute of Biological Products Corporation Information
6.4.2 Wuhan Institute of Biological Products Overview
6.4.3 Wuhan Institute of Biological Products Pertussis Vaccine Sales and Revenue in United States Market (2016-2021)
6.4.4 Wuhan Institute of Biological Products Pertussis Vaccine Product Description
6.4.5 Wuhan Institute of Biological Products Recent Developments
6.5 Walvax Biotechnology
6.5.1 Walvax Biotechnology Corporation Information
6.5.2 Walvax Biotechnology Overview
6.5.3 Walvax Biotechnology Pertussis Vaccine Sales and Revenue in United States Market (2016-2021)
6.5.4 Walvax Biotechnology Pertussis Vaccine Product Description
6.5.5 Walvax Biotechnology Recent Developments
6.6 Minhai Biotechnology
6.6.1 Minhai Biotechnology Corporation Information
6.6.2 Minhai Biotechnology Overview
6.6.3 Minhai Biotechnology Pertussis Vaccine Sales and Revenue in United States Market (2016-2021)
6.6.4 Minhai Biotechnology Pertussis Vaccine Product Description
6.6.5 Minhai Biotechnology Recent Developments
7 United States Pertussis Vaccine Production Capacity, Analysis
7.1 United States Pertussis Vaccine Production Capacity, 2016-2027
7.2 Pertussis Vaccine Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Pertussis Vaccine Supply Chain Analysis
9.1 Pertussis Vaccine Industry Value Chain
9.2 Pertussis Vaccine Upstream Market
9.3 Pertussis Vaccine Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Pertussis Vaccine Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of TablesTable 1. Key Players of Pertussis Vaccine in United States Market
Table 2. Top Pertussis Vaccine Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Pertussis Vaccine Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Pertussis Vaccine Revenue Share by Companies, 2016-2021
Table 5. United States Pertussis Vaccine Sales by Companies, (M Doses), 2016-2021
Table 6. United States Pertussis Vaccine Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Pertussis Vaccine Price (2016-2021) & (USD/Doses)
Table 8. Manufacturers Pertussis Vaccine Product Type
Table 9. List of Tier 1 Pertussis Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Pertussis Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Whole-cell Vaccines
Table 12. Major Manufacturers of Acellular Vaccines
Table 13. By Type - United States Pertussis Vaccine Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Pertussis Vaccine Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Pertussis Vaccine Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Pertussis Vaccine Sales (M Doses), 2016-2021
Table 17. By Type - United States Pertussis Vaccine Sales (M Doses), 2022-2027
Table 18. By Application - United States Pertussis Vaccine Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Pertussis Vaccine Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Pertussis Vaccine Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Pertussis Vaccine Sales (M Doses), 2016-2021
Table 22. By Application - United States Pertussis Vaccine Sales (M Doses), 2022-2027
Table 23. Sanofi Pasteur Corporation Information
Table 24. Sanofi Pasteur Description and Major Businesses
Table 25. Sanofi Pasteur Pertussis Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Doses) (2016-2021)
Table 26. Sanofi Pasteur Pertussis Vaccine Product
Table 27. Sanofi Pasteur Recent Developments
Table 28. GSK Corporation Information
Table 29. GSK Description and Major Businesses
Table 30. GSK Pertussis Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Doses) (2016-2021)
Table 31. GSK Pertussis Vaccine Product
Table 32. GSK Recent Developments
Table 33. Mitsubishi Tanabe Pharma Corporation Information
Table 34. Mitsubishi Tanabe Pharma Description and Major Businesses
Table 35. Mitsubishi Tanabe Pharma Pertussis Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Doses) (2016-2021)
Table 36. Mitsubishi Tanabe Pharma Pertussis Vaccine Product
Table 37. Mitsubishi Tanabe Pharma Recent Developments
Table 38. Wuhan Institute of Biological Products Corporation Information
Table 39. Wuhan Institute of Biological Products Description and Major Businesses
Table 40. Wuhan Institute of Biological Products Pertussis Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Doses) (2016-2021)
Table 41. Wuhan Institute of Biological Products Pertussis Vaccine Product
Table 42. Wuhan Institute of Biological Products Recent Developments
Table 43. Walvax Biotechnology Corporation Information
Table 44. Walvax Biotechnology Description and Major Businesses
Table 45. Walvax Biotechnology Pertussis Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Doses) (2016-2021)
Table 46. Walvax Biotechnology Pertussis Vaccine Product
Table 47. Walvax Biotechnology Recent Developments
Table 48. Minhai Biotechnology Corporation Information
Table 49. Minhai Biotechnology Description and Major Businesses
Table 50. Minhai Biotechnology Pertussis Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Doses) (2016-2021)
Table 51. Minhai Biotechnology Pertussis Vaccine Product
Table 52. Minhai Biotechnology Recent Developments
Table 53. Pertussis Vaccine Production Capacity (M Doses) of Key Manufacturers in United States Market, 2019-2021 (M Doses)
Table 54. United States Pertussis Vaccine Capacity Market Share of Key Manufacturers, 2019-2021
Table 55. Pertussis Vaccine Market Opportunities & Trends in United States Market
Table 56. Pertussis Vaccine Market Drivers in United States Market
Table 57. Pertussis Vaccine Market Restraints in United States Market
Table 58. Pertussis Vaccine Raw Materials
Table 59. Pertussis Vaccine Raw Materials Suppliers in United States Market
Table 60. Typical Pertussis Vaccine Downstream
Table 61. Pertussis Vaccine Downstream Clients in United States Market
Table 62. Pertussis Vaccine Distributors and Sales Agents in United States Market
List of FiguresFigure 1. Pertussis Vaccine Product Picture
Figure 2. Pertussis Vaccine Segment by Type
Figure 3. Pertussis Vaccine Segment by Application
Figure 4. United States Pertussis Vaccine Market Overview: 2020
Figure 5. United States Pertussis Vaccine Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Pertussis Vaccine Revenue, 2016-2027 (US$, Mn)
Figure 7. Pertussis Vaccine Sales in United States Market: 2016-2027 (M Doses)
Figure 8. The Top 3 and 5 Players Market Share by Pertussis Vaccine Revenue in 2020
Figure 9. Whole-cell Vaccines Product Picture
Figure 10. Acellular Vaccines Product Picture
Figure 11. By Type - United States Pertussis Vaccine Sales Market Share, 2016-2027
Figure 12. By Type - United States Pertussis Vaccine Revenue Market Share, 2016-2027
Figure 13. By Type - United States Pertussis Vaccine Price (USD/Doses), 2016-2027
Figure 14. Children
Figure 15. Adults
Figure 16. By Application - United States Pertussis Vaccine Sales Market Share, 2016-2027
Figure 17. By Application - United States Pertussis Vaccine Revenue Market Share, 2016-2027
Figure 18. By Application - United States Pertussis Vaccine Price (USD/Doses), 2016-2027
Figure 19. Sanofi Pasteur Pertussis Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 20. GSK Pertussis Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. Mitsubishi Tanabe Pharma Pertussis Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Wuhan Institute of Biological Products Pertussis Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Walvax Biotechnology Pertussis Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Minhai Biotechnology Pertussis Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. United States Pertussis Vaccine Production Capacity (M Doses), 2016-2027
Figure 26. Pertussis Vaccine Industry Value Chain
Figure 27. Marketing Channels